Is Melanoma Progression Affected by Thyroid Diseases? Salvatore Ulisse et al, 2022, International Journal of Molecular Sciences CrossRef
The Changing Face of in vitro Culture Models for Thyroid Cancer Research: A Systematic Literature Review Dylan Chew et al, 2020, Frontiers in Surgery CrossRef
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics Ichiro Abe et al, 2021, Current Oncology Reports CrossRef
Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy Takuya Sho et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
Advanced Differentiated Thyroid Cancer: A Complex Condition Needing a Tailored Approach Antonio Mario Bulfamante et al, 2022, Frontiers in Oncology CrossRef
Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
Xi Su et al, 2020, OncoTargets and Therapy CrossRef
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration Silvia Martina Ferrari et al, 2018, Frontiers in Endocrinology CrossRef
PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications Salvatore Ulisse et al, 2019, International Journal of Molecular Sciences CrossRef
Papillary Thyroid Cancer Prognosis: An Evolving Field Salvatore Ulisse et al, 2021, Cancers CrossRef
Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer Yu-Ling Lu et al, 2021, Cancers CrossRef
Lenvatinib-induced severe interstitial pneumonia in a patient with hepatocellular carcinoma: A case report Yuki Ikeda et al, 2021, Kanzo CrossRef
Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma Laurys Boudin et al, 2022, Current Oncology CrossRef
Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models Keisuke Enomoto et al, 2021, Cancers CrossRef